2022 annual financial data

Cullinan Therapeutics 2022 Financial results

Direct answer

Revenue was 0 USD.

Operating income was 144,648,000 USD and net income was 111,214,000 USD.
Operating cash flow was -126,664,000 USD.

Get free Cullinan Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
144,648,000 USD
Net income
111,214,000 USD
Operating cash flow
-126,664,000 USD